These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23536347)

  • 21. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms.
    Hemminger J; Iwenofu OH
    Histopathology; 2012 Aug; 61(2):170-7. PubMed ID: 22571292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
    Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
    Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
    Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (non-GIST) neoplasms.
    Tang YL; Wong CF; Yap WM; Chuah KL
    Histopathology; 2014 Nov; 65(5):724-6. PubMed ID: 24713079
    [No Abstract]   [Full Text] [Related]  

  • 25. Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic Factors.
    Liu Q; Wang Y; Kong L; Kan Y
    Cell Biochem Biophys; 2015 Dec; 73(3):743-7. PubMed ID: 27259319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
    Şahin S; Ekinci Ö; Seçkin S; Dursun A
    Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histology and molecular biology of GIST].
    Emile JF
    Bull Acad Natl Med; 2012; 196(4-5):835-44. PubMed ID: 23550446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and morphological correlation in gastrointestinal stromal tumours (GISTs): an update and primer.
    Chetty R; Serra S
    J Clin Pathol; 2016 Sep; 69(9):754-60. PubMed ID: 27317811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment.
    Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR
    Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intrapelvic extraintestinal gastrointestinal stromal tumor of undetermined origin: diagnosis by prostate needle biopsy.
    Takahashi RH; Matsubayashi J; Yokotsuka M; Tachibana M; Kusama H; Nagao T
    Pathol Res Pract; 2012 Dec; 208(12):736-40. PubMed ID: 23057997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of Rab27B nuclear expression in gastrointestinal stromal tumors.
    Wang W; Ni Q; Wang H; Zhang S; Zhu H
    Dis Markers; 2014; 2014():942181. PubMed ID: 25382899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of SSH1 in gastrointestinal stromal tumors].
    Maimaitiaili M; Yu SF; Ke LM
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(10):754-757. PubMed ID: 30884629
    [No Abstract]   [Full Text] [Related]  

  • 34. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
    Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
    World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.
    Montgomery E; Torbenson MS; Kaushal M; Fisher C; Abraham SC
    Am J Surg Pathol; 2002 Oct; 26(10):1296-301. PubMed ID: 12360044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases.
    Bülbül Doğusoy G;
    Turk J Gastroenterol; 2012 Jun; 23(3):203-11. PubMed ID: 22798108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological and immunohistochemical analysis of gastrointestinal, urinary and perineal stromal tumors].
    Yu GH; Ni XH; Qian F; Chen LH
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):111-4. PubMed ID: 12839670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
    Swalchick W; Shamekh R; Bui MM
    Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine Gastrointestinal Spindle Cell Tumors Efficiently Diagnosed by Tissue Microarray-Based Immunohistochemistry.
    Pellegrino V; Muscatello LV; Sarli G; Avallone G
    Vet Pathol; 2018 Sep; 55(5):678-681. PubMed ID: 29807498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.